Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts

Pancreatic duct stent placement is increasingly performed for the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP); however stents can result in injury especially in normal ducts. The clinical significance and outcomes of subsequent endoscopic therapy are unknown. This study was a retrospective review of the management of symptomatic stent-induced pancreatic duct injury following stent placement for prevention of post-ERCP pancreatitis in eight patients with previously normal pancreatic ducts. Subsequent treatment included pancreatic sphincterotomy, balloon dilation of stricture, and placement of multiple 3 – 5-Fr soft polymer pancreatic stents. All patients showed improvement or resolution of pancreatic strictures. Five patients had resolution or substantial improvement of pain, one patient showed a fair response with repeated ERCPs, and two patients failed to respond and underwent total pancreatectomy with islet autotransplantation. Pancreatic duct stent-induced ductal injury with significant clinical consequences can occur with conventional polyethylene stents. Endoscopic therapy is moderately effective but some patients develop irreversible damage. Caution should be used when placing standard polyethylene stents in normal ducts. Further research is required to identify safer materials and configurations of pancreatic stents.

References

• 1 Freeman M L, Guda N M. Prevention of post-ERCP pancreatitis: a comprehensive review.  Gastrointest Endosc. 2004;  59 845-864
• 2 Tarnasky P R, Palesch Y Y, Cunningham J T. et al . Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.  Gastroenterology. 1998;  115 1518-1524
• 3 Fazel A, Quadri A, Catalano M F. et al . Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.  Gastrointest Endosc. 2003;  57 291-294
• 4 Freeman M L. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.  Clin Gastroenterol Hepatol. 2007;  5 1354-1365
• 5 Singh P, Das A, Isenberg G. et al . Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.  Gastrointest Endosc. 2004;  60 544-550
• 6 Rashdan A, Fogel E L, McHenry L Jr.. et al . Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.  Clin Gastroenterol Hepatol. 2004;  4 322-329
• 7 Smith M T, Sherman S, Ikenberry S O. et al . Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.  Gastrointest Endosc. 1996;  44 268-275
• 8 Sherman S, Hawes R H, Savides T J. et al . Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP.  Gastrointest Endosc. 1996;  44 276-282
• 9 Sherman S, Alvarez C, Robert M. et al . Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas.  . 1993;  39 658-664
• 10 Siegel J, Veerappan A. Endoscopic management of pancreatic disorders: potential risks of pancreatic prostheses.  Endoscopy. 1991;  23 177-180
• 11 Kozarek R A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.  Gastrointest Endosc. 1990;  36 93-95
• 12 Blondet J J, Carlson A M, Kobayashi T. et al . The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis.  Surg Clin North Am. 2007;  87 1477-1501
• 13 Sofuni A, Maguchi H, Itoi T. et al . Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.  Clin Gastroenterol Hepatol. 2007;  5 1339-1346
• 14 Brackbill S, Young S, Schoenfeld P, Elta G. A survey of physician practices on prophylactic pancreatic stents.  Gastrointest Endosc. 2006;  64 45-52